Potential for truncating the scan length of restaging FDG-PET/CT after chemoradiotherapy in head and neck squamous cell carcinoma

Nuclear Medicine Communications

Volumn 33, Issue 5, 2012, Pages 503-508

  Huang, Yi Tung Tom ^a,c   Ravi Kumar, Aravind S ^a,b,c  

^a Queensland PET Service   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

fluorodeoxyglucose; head and neck; positron emission tomography computed tomography; restaging; squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84862827177     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32835095d8     Document Type: Article

References (17)

1. Senft A, de Bree R, Hoekstra OS, Kuik DJ, Golding RP, Oyen WJG, et al. Screening for distant metastases in head and neck cancer patients by chest CTor whole body FDG-PET: a prospective multicenter trial. Radiother Oncol 2008; 87:221-229.
2. Leon X, Quer M, Orus C, del Prado Venegas M, Lopez M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 2000; 22:680-686.
3. Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2001; 63:202-207. (Pubitemid 32620169)
4. Leemans CR, Tiwari R, Nauta JJP, Van der Wall I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71:452-456. (Pubitemid 23021234)
5. Alvi A, Johnson JT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 1997; 19:500-505. (Pubitemid 27349669)
6. Doweck I, Robbins KM, Vieira F. Analysis of risk factors predictive of distant failure after targeted chemoradiation for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2001; 127:1315-1318. (Pubitemid 33041895)
7. Garavello W, Ciardo A, Spreafico R, Gaini RM. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132:762-766. (Pubitemid 44086440)
8. Ljumanovic R, Langendijk JA, Hoekstra OS, Leemans CR, Castelijns JA. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Eur J Radiol 2006; 60:58-66. (Pubitemid 44404160)
9. Porceddu SV, Burmeister BH, Hicks RJ. Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond. Hematol Oncol Clin N Am 2008; 22:1221-1238.
10. Schoder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carinoma. J Nucl Med 2009; 50:74 S-88 S.
11. Yao M, Graham MM, Smith RB, Dornfeld KJ, Skwarchuk M, Hoffman HT, et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 2004; 60:1410-1418. (Pubitemid 39610495)
12. Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, et al. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2005; 63:991-999. (Pubitemid 41505274)
13. Porceddu SV, Jarmolowski E, Hicks RJ,Ware R,Weih L, Corry J, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer. Head Neck 2005; 27:175-181. (Pubitemid 40315765)
14. Ong SC, Schoder H, Lee NY, Patel SG, Carlson D, Fury M, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer. J Nucl Med 2008; 49:532-540. (Pubitemid 351520600)
15. Segall GM. A new paradigm to increase utilization of PET/CT. J Nucl Med 2008; 49:53N-56N.
16. The Joint Commission. Sentinel Event Alert: radiation risks of diagnostic imaging, 24 August 2001, http://www.jointcommission.org/assets/1/18/ SEA-471.PDF [Accessed 29 August 2011].
17. Lagaru A, Mittra ES, Gambhir SS. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning? Mol Imaging Biol 2011; 13:362-367.